METHODS
We carried out a retrospective cohort study of all abdominoplasty and panniculectomy cases performed at a single institution from 2007 to 2015. Demographic and perioperative data were collected through chart review, and univariate analysis were performed on baseline characteristics. Two multivariate regression analyses were performed to assess the effect of body mass index (BMI) on surgical-site occurrence (SSO). In the first regression analysis, the cohort of interest was defined as BMI ≥ 30.0, and in the second regression analysis the cohort of interest was defined as BMI ≥ 35.0. Statistical analysis was performed using SAS University Edition software.
RESULTS
One hundred seven patients met inclusion criteria (84.1% female; mean age, 46). Average BMI of the population was 32.5, where 53.3% of patients had BMI ≥ 30, and 28.0% of patients had BMI ≥ 35.0. In total, 18.7% of patients experienced SSO, including wound separation 14.0%, dehiscence 6.5%, skin necrosis 2.8%, fat necrosis 0.9%, infection 6.5%, postoperative intravenous antibiotics 2.8%, postoperative oral antibiotics 5.6%, postoperative topical antibiotics 2.8%, cellulitis 2.8%, abscess formation 3.7%, hematoma formation 1.9%, and seroma formation 6.5%. Using multivariate regression, we assessed the effect of age, sex, procedure type, preoperative antibiotic treatment, presence of comorbidities, and BMI ≥ 30.0 or ≥ 35.0 on development of surgical-site complications in our patients. Medical comorbidities [odds ratio (OR) = 3.68; CI = 1.02-13.23; P < 0.05] and BMI ≥ 35.0 (OR = 6.71; CI = 2.09-21.48; P < 0.01) were independent predictors for SSO; however, subsequent cohort analysis revealed that BMI ≥ 30.0 was not predictive of SSO. Additionally, BMI ≥ 35.0 was an independent predictor of hospital readmission within 30 days postoperatively (OR = 15.20; CI = 1.69-136.34; P < 0.05).
CONCLUSIONS
Patients who undergo body contouring procedures following massive weight loss are at greater risk for postoperative complications. Both the presence of medical comorbidities and BMI of 35 or above were independent predictors of surgical-site occurrences.
